Add to MyYahoo RSS

Biotech News

Biotech news continually updated from thousands of sources around the net.

1 hr ago |

Tuesday's ETF Movers: XBI, XLU

Our mission at Market News Video is to produce and distribute quality online videos about the stock markets and publicly traded companies.


Related Topix: Arrowhead Research, Isis Pharmaceuticals, Medicine, Healthcare Industry, Financial Markets

Tue Aug 26, 2014

Sys-Con Media

IDEXX Laboratories marks 30th year with a new, LEEDA Gold Corporate Headquarters

As a whole, it is the heart of innovation within the IDEXX Corporation, and successfully concludes Phase II of the master plan crafted by Lavallee Brensinger Architects of , Principal-In-Charge at Lavallee Brensinger, IDEXX made its design objectives for the new 108,000 square foot building clear from the start.


Related Topix: IDEXX Laboratories, Medicine, Healthcare Industry, Arts, Interior Design


Allergan, facing shareholder demands, calls special meeting for December 18

Allergan Inc said on Tuesday that it has scheduled a special shareholders meeting for Dec. 18, when activist investor Bill Ackman, who supports a hostile bid for the company by Valeant Pharmaceuticals Inc, will attempt to oust most of its board.


Related Topix: Allergan


Biotech Stocks: Time to Worry

I mean, just look at these returns: Gilead Sciences has gained 41% so far this year as investors appear to have put their Sovaldi worries behind them ; InterMune has quintupled in 2014 after Roche agreed to purchase it for $8.3 billion ; and Intercept Pharmaceuticals has surged 350% as drug trials have been surprisingly good .


Related Topix: Science / Technology, Financial Markets, Medicine, Gilead Sciences, Healthcare Industry, Startups, CGI Pharmaceuticals, InterMune


Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.


Related Topix: Pfizer, Merck , Medicine, Healthcare Industry, Health, Lung Cancer

Roche pays $8.3bn for drug's potential

Swiss pharmaceutical company Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash in order to get hold of a promising respiratory drug, in the latest multibillion-dollar deal in a consolidating pharmaceutical and biotechnology sector.


Related Topix: Science / Technology, Genentech, Startups, Reuters, Medicine, Pulmozyme, Dornase Alfa (generic), California

Business Journal

Biotech is in a microbial state in New York City, but Samuel Sia will let you use the Petri dish

Samuel K. Sia: "The biospace area is the one that has the most potential that people don't know about."


Related Topix: Science / Technology, New York, Columbia University

Mon Aug 25, 2014

New experimental GMOs cause Public outrage after USDA colludes with biotech industry

Despite a groundswell of opposition from watchdog groups, doctors, scientists, 50 members of Congress and thousands of members of the general public, the U.S. Department of Agriculture has decided to move forward with approval for three new genetically modified crops designed to be sprayed with Dow AgroScience's Enlist Duo herbicide, which contains ... (more)


Related Topix: United States Department of Agriculture, US News, Agriculture, Science

S&P 500 sets record high, can't hold 2,000

The significance of the milestone was more psychological than fundamental, and it represents the high point of a nearly six-year rally that has boosted retirement accounts for Americans from Wall Street to Main Street, though the gains have largely benefited wealthier Americans.


Related Topix: Science / Technology, Financial Markets, Main Street and Main, Restaurant Management

Business Journal

CDC Foundation gets $1M grant to fight Ebola

Latest numbers from the CDC cite more than 2,600 cases of Ebola and 1,400 deaths reported in Guinea, Liberia, Nigeria and Sierra Leone, the four countries affected by the outbreak thus far.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry, Robert Wood Johnson Foundation, Charitable Organizations

WAPT-TV Jackson

Ebola: Your most pressing questions answered

The largest Ebola outbreak in history has struck fear into the hearts of people around the world.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry

The Globe and Mail

Valeant acquires dermatology portfolio and speciality products from Valeo

The head office and logo of Valeant Pharmaceutical are pictured in Montreal on Monday May 27, 2013.


Related Topix: Medicine, Dermatology, Allergan


Advaxis, Merck to test immune therapies against prostate cancer

Advaxis Inc on Monday said it will test an experimental immuno-oncology drug in combination with a high-profile immunotherapy from Merck & Co Inc as a treatment for patients with advanced prostate cancer.


Related Topix: Merck , Prostate Cancer, Medicine, Healthcare Industry, Oncology

Sun Aug 24, 2014

Business Wire

Press release distribution, EDGAR filing, XBRL, regulatory filings

The ES is a flexible, highly st... )--Edwards launches new range of single stage oil sealed rotary vane pumps to the Taiwan market at Touch Panel Optical Film Exhibition, Taiwan.


Related Topix: InterMune, Medicine, Healthcare Industry


Kent Brantley, U.S. Missionary Doctor, Discharged After Recovering From Ebola

An American doctor treated for Ebola, Kent Brantly, was discharged from Atlanta's Emory University Hospital Thursday .


Related Topix: Medicine, Nursing, Christian Music, RNS, Infectious Diseases, Centers for Disease Control and Prevention, Healthcare Industry

The Motley Fool

Biotech Investing: 3 Ways You're Doing It Wrong

When it comes to industries that offer investors a higher than average risk-versus-reward scenario, biotech investing arguably takes the cake.


Related Topix: Science / Technology, Intercept Pharmaceuticals, Financial Markets

Washington Examiner

Roche to buy US biotech firm InterMune for $8.3B

Swiss pharmaceutical company Roche said Sunday it has reached an $8.3 billion deal to buy InterMune Inc., a California-based developer of treatments for lung diseases.


Related Topix: InterMune, Medicine, Healthcare Industry, Science / Technology, San Mateo County, CA, Brisbane, CA

WKYC-TV Cleveland

STUDY | Fewer teens wearing sunscreenSTUDY | Fewer teens wearing...

Fewer teens wearing sunscreen A new study from the Check out this story on A recent study from the Centers for Disease Control and Prevention shows the percentage of high school students who reported using sunscreen fell from nearly 68 percent in 2001 to 56 percent in 2011.


Related Topix: Centers for Disease Control and Prevention, Medicine, Healthcare Industry, Education Etc.


Take pro-poor stand & promote GM crops to provide food security to...

Apex industry body ASSOCHAM today urged the Central Government to continue allowing research in crop biotechnology and simultaneously identify areas to develop a more strong regulatory system for India to become global food hub.


Related Topix: Agriculture, Science, Science / Technology, Genetics, Medicine, Weather, Natural Disasters, Drought, Life, Food, Vegetables

The Indianapolis Star

Black box' warning on antidepressants vastly reduced lawsuitsa

The days of the big-bucks lawsuits that focused attention on when people commit horrific acts while on antidepressants have pretty much subsided.


Related Topix: Medicine, Eli Lilly, Healthcare Industry, Healthcare Law, Law, Food and Drug Administration, Pennsylvania


Biotech Jobs